Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,227 public trials 1,016 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.

NCT02292550

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Bologna, BO, Italy
  • Novartis Investigative Site Rozzano, MI, Italy
View Trial Details
Completed

An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)

NCT00674102

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Aichi, Japan
  • Novartis Investigative Site Osaka, Japan
  • Novartis Investigative Site Shizuoka, Japan
  • Novartis Investigative Site Tokyo, Japan
View Trial Details
Completed

Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer

NCT03098030

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Cancer Treatment Centers of America - Western Regional Medical Center Goodyear, Arizona, United States
  • Innovative Clinical Research Institute Tucson, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
View all 226 locations
View Trial Details
Completed

A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients

NCT01639001

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The First Affiliated Hospital of Anhui Medical University, Department of Medical Oncology Hefei, Anhui, China
  • Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Dept. of Respiration. Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 47 locations
View Trial Details
Completed

Study of Nivolumab for Advanced Cancers in India

NCT03444766

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Local Institution Bangalore, India
  • Local Institution Bangalore, India
  • Local Institution Bengaluru, India
  • Local Institution Hyderabad, India
View Trial Details
Completed

Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer

NCT01958372

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +21 more
Locations
  • Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute at McLaren Lapeer Region Lapeer, Michigan, United States
  • Karmanos Cancer Institute at McLaren Central Michigan Mount Pleasant, Michigan, United States
View Trial Details
Completed

Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.

NCT04640935

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hôpital Ambroise Paré AP-HP Boulogne-Billancourt, France
  • Centre Hospitalier Universitaire Brest Brest, France
  • Centre Hospitalier Métropole Savoie Chambéry, France
  • Centre Hospitalier Intercommunal de Créteil Créteil, France
View all 15 locations
View Trial Details

Related conditions